Taking Action On Diversity, BIO Challenges CEOs To Pursue Business Benefits
Executive Summary
Scrip spoke with Halozyme CEO Helen Torley, chair of BIO's Workforce Development, Diversity and Inclusion committee, about efforts to communicate the benefits of diverse leadership to CEOs and build a database of diverse board candidates.
You may also be interested in...
Biotech’s Double-Edged Sword: Extraordinary Funding Run Contributes To Talent Crisis
Finding good leaders always has been hard, but record-breaking VC investment and IPOs, COVID-19 and diversity initiatives have compounded the growing problem.
Leading A Diverse Company: Biopharma Executives Offer Ways Forward
BIO hosted discussions during its annual meeting to reinforce the value of inclusion, offer advice to companies and reflect on recent US events.
Leading A Diverse Company: Biopharma Executives Offer Ways Forward
BIO hosted discussions during its annual meeting to reinforce the value of inclusion, offer advice to companies and reflect on recent US events.